RASA2 Polyclonal Antibody

The protein encoded by this gene is member of the GAP1 family of GTPase-activating proteins. The gene product stimulates the GTPase activity of normal RAS p21 but not its oncogenic counterpart. Acting as a suppressor of RAS function, the protein enhances the weak intrinsic GTPase activity of RAS proteins resulting in the inactive GDP-bound form of RAS, thereby allowing control of cellular proliferation and differentiation. Alternative splicing results in multiple transcript variants.

Introducing the RASA2 Polyclonal Antibody, a cutting-edge biotechnological solution designed to revolutionize the field of molecular research. This meticulously crafted antibody is meticulously engineered to target the RASA2 protein, enabling researchers to delve deeper into the intricate mechanisms of cellular signaling pathways.

The RASA2 Polyclonal Antibody boasts exceptional specificity and sensitivity, ensuring accurate and reliable results in a wide range of applications. Its high affinity for the RASA2 protein allows for precise detection and quantification, facilitating comprehensive analysis of cellular processes.

Crafted with utmost precision, this antibody undergoes rigorous quality control measures to guarantee optimal performance and reproducibility. Its exceptional purity and stability ensure consistent results, making it an indispensable tool for researchers striving for scientific excellence.

The RASA2 Polyclonal Antibody is compatible with various experimental techniques, including Western blotting, immunohistochemistry, and immunofluorescence. Its versatility allows for seamless integration into diverse research projects, empowering scientists to explore the intricate complexities of cellular signaling pathways with unparalleled accuracy.

With its unrivaled performance and reliability, the RASA2 Polyclonal Antibody is poised to revolutionize the field of molecular research. Unlock the secrets of cellular signaling pathways with confidence and precision, and elevate your scientific endeavors to new heights with this groundbreaking biotechnological marvel.